98 related articles for article (PubMed ID: 12009671)
1. Bacterial infection of human skin allograft mimics the rejection process.
Moscicka-Wesolowska M; Olszewski WL; Zolich D; Stelmach E
Transplant Proc; 2002 Mar; 34(2):701-2. PubMed ID: 12009671
[No Abstract] [Full Text] [Related]
2. Survival of fetal skin grafts is prolonged on the human peripheral blood lymphocyte reconstituted-severe combined immunodeficient mouse/skin allograft model.
Erdag G; Morgan JR
Transplantation; 2002 Feb; 73(4):519-28. PubMed ID: 11889422
[TBL] [Abstract][Full Text] [Related]
3. The allogeneic response to cultured human skin equivalent in the hu-PBL-SCID mouse model of skin rejection.
Briscoe DM; Dharnidharka VR; Isaacs C; Downing G; Prosky S; Shaw P; Parenteau NL; Hardin-Young J
Transplantation; 1999 Jun; 67(12):1590-9. PubMed ID: 10401767
[TBL] [Abstract][Full Text] [Related]
4. Chronic human skin graft rejection in severe combined immunodeficient mice engrafted with human PBL from an HLA-presensitized donor.
Kawamura T; Niguma T; Fechner JH; Wolber R; Beeskau MA; Hullett DA; Sollinger HW; Burlingham WJ
Transplantation; 1992 Mar; 53(3):659-65. PubMed ID: 1549862
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic versus xenogeneic immune reaction to bioengineered skin grafts.
Erdag G; Morgan JR
Cell Transplant; 2004; 13(6):701-12. PubMed ID: 15648740
[TBL] [Abstract][Full Text] [Related]
6. Mediation of skin allograft rejection in scid mice by CD4+ and CD8+ T cells.
Shelton MW; Walp LA; Basler JT; Uchiyama K; Hanto DW
Transplantation; 1992 Aug; 54(2):278-86. PubMed ID: 1353912
[TBL] [Abstract][Full Text] [Related]
7. Skin allografts--lymph veiled (dendritic) cells are responsible for initiation of rejection in canine skin/SCID mouse chimera model.
Galkowska H; Olszewski WL; Moscicka M; Cybulska E; Ziolkowska A; Wojewodzka U; Mijal J
Ann Transplant; 1999; 4(3-4):5-10. PubMed ID: 10853773
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of cellular reaction to alloantigens and bacterial infection in human skin graft--immunosuppressive drugs or antibiotics.
Moscicka-Wesolowska M; Olszewski WL; Zolich D; Stelmach E
Ann Transplant; 2002; 7(4):25-7. PubMed ID: 12854343
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic and xenogeneic vascular injury and protection.
Pober JS; Schechner JS; Murray AG; Sultan P; Kirkiles N; Tereb D; Wilson J; McNiff JM; Askenase PW; Tellides G; Lorber MI
Transplant Proc; 1998 Dec; 30(8):4168-9. PubMed ID: 9865336
[No Abstract] [Full Text] [Related]
10. Alloimmune injury and rejection of human skin grafts on human peripheral blood lymphocyte-reconstituted non-obese diabetic severe combined immunodeficient beta2-microglobulin-null mice.
Turgeon NA; Banuelos SJ; Shultz LD; Lyons BL; Iwakoshi N; Greiner DL; Mordes JP; Rossini AA; Appel MC
Exp Biol Med (Maywood); 2003 Oct; 228(9):1096-104. PubMed ID: 14530522
[TBL] [Abstract][Full Text] [Related]
11. Extended and expanded studies of xenograft rejection in immunodeficient animals.
Thomas F; Araneda D; Henretta J; Pittman K; Marchman W
Transplant Proc; 1994 Jun; 26(3):1224-7. PubMed ID: 8029895
[No Abstract] [Full Text] [Related]
12. The effect of cyclosporine and tacrolimus on indigenous bacterial flora in human skin grafts.
Moscicka M; Olszewski WL; Zolich D
Transplant Proc; 2003 Sep; 35(6):2361-2. PubMed ID: 14529942
[TBL] [Abstract][Full Text] [Related]
13. Human myeloid dendritic cells transduced with an adenoviral interleukin-10 gene construct inhibit human skin graft rejection in humanized NOD-scid chimeric mice.
Coates PT; Krishnan R; Kireta S; Johnston J; Russ GR
Gene Ther; 2001 Aug; 8(16):1224-33. PubMed ID: 11509955
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous CsA-resistant veiled (dendritic) cells are responsible for uncontrolled skin allograft rejection.
Galkowska H; Moscicka M; Cybulska E; Wojewodzka U; Mijal J; Olszewski WL
Transplant Proc; 2001; 33(1-2):445-7. PubMed ID: 11266902
[No Abstract] [Full Text] [Related]
15. Islet allograft, islet xenograft, and skin allograft survival in CD8+ T lymphocyte-deficient mice.
Desai NM; Bassiri H; Kim J; Koller BH; Smithies O; Barker CF; Naji A; Markmann JF
Transplantation; 1993 Apr; 55(4):718-22. PubMed ID: 8475541
[TBL] [Abstract][Full Text] [Related]
16. Effect of primary xenograft or allograft on the rejection of a subsequent allograft.
Tchervenkov CI; Shum-Tim D; Serrick CJ; Gyopar A; Lough JO; Tchervenkov JI
Transplant Proc; 1993 Feb; 25(1 Pt 1):453-4. PubMed ID: 8438376
[No Abstract] [Full Text] [Related]
17. Allograft and xenograft rejection in C3H/SCID mice. A new model for the study of non-T cell graft rejection mechanisms.
Marcus H; FActorovich Y; Kulova L; Denes L; Segal H; David M; Burakova T; Reisner Y
Transplantation; 1996 Mar; 61(5):777-83. PubMed ID: 8607183
[TBL] [Abstract][Full Text] [Related]
18. Human T-cell-mediated destruction of allogeneic dermal microvessels in a severe combined immunodeficient mouse.
Murray AG; Petzelbauer P; Hughes CC; Costa J; Askenase P; Pober JS
Proc Natl Acad Sci U S A; 1994 Sep; 91(19):9146-50. PubMed ID: 8090783
[TBL] [Abstract][Full Text] [Related]
19. Effector cells must recognize antigens expressed in the graft to cause efficient skin graft rejection in SCID mice.
Wecker H; Grusby MJ; Auchincloss H
Transplantation; 1995 Apr; 59(8):1223-7. PubMed ID: 7732570
[No Abstract] [Full Text] [Related]
20. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K
Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
